UPDATE 1-Lilly says Cymbalta maintains pain reduction in study | Reuters
Links shared publicly online about this topic.
- 1,757total visits
UPDATE 1-Lilly says Cymbalta maintains pain reduction in study | Reuters
* 181 patients enrolled in 41-wk extension phase of study * Further pain reduction on Cymbalta shown in extension phase Sept 11 (Reuters) - Eli Lilly and Co said new data showed that
View full resource at reuters.com
Tags: Pain, Anxiety Medication, Antidepressant, Fibromyalgia Medication, Neuropathic Pain Medication, Cymbalta, Eli Lilly and Company
Most Recently Shared on September 11, 2009 at 1:28 pm By:
Lilly says Cymbalta maintains pain reduction in study - Reuters http://bit.ly/ZjgJ9
Advertisement
